2021-006669-40
Plasma cell depletion as an approach to reset autoimmunity in rheumatoid arthritis
Universitätsklinikum Erlangen·EU Clinical Trials RegisterOngoing
Study focus
- Disease/Condition
- Rheumatoid arthritis
Sponsor & location
- Primary sponsor
- Universitätsklinikum Erlangen
- Funder
- Janssen-Cilag GmbH
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
• Planned or ongoing pregnancy or breast-feeding
ICD-10 classifications
Rheumatoid arthritis, unspecifiedOther rheumatoid arthritisOther specified rheumatoid arthritisRheumatoid arthritis with involvement of other organs and systemsSeronegative rheumatoid arthritis
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2021-006669-40
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2021-006669-40 through Pure Global AI's free database. This phase not specified trial is sponsored by Universitätsklinikum Erlangen and is currently Ongoing. The study focuses on Rheumatoid arthritis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.